Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. [electronic resource]
- Journal of microencapsulation Jun 2019
- 338-355 p. digital
Publication Type: Journal Article
1464-5246
10.1080/02652048.2019.1631401 doi
Animals Bone Density--drug effects Bone Density Conservation Agents--administration & dosage Chitosan--chemistry Drug Carriers--chemistry Female Nanoparticles--chemistry Osteoporosis--drug therapy Rats, Wistar Risedronic Acid--administration & dosage